Connect with Fogarty
Fogarty researchers in India and South Africa develop a low-cost tool to determine heart disease risk
Fogarty and NIH support a diverse mix of research projects in sub-Saharan Africa with significant activities in approximately 20 African countries. About a third of the funding supports groundbreaking research and research training on HIV/AIDS and sexually transmitted diseases, including a substantial effort to study mother-to-child transmission of HIV. Around 20 percent funds research on other infectious diseases, ranging from population-based research on malaria, schistosomiasis and leishmaniasis, to molecular research on vectors and parasites. Chronic disease research makes up about 12 percent of the research portfolio, with the remainder devoted to child development, biodiversity, basic research and other studies.
Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Cape Verde, Central Africa Republic, Chad, Comoros, Democratic Republic of Congo, Ivory Coast, Djibouti, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Kenya, Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Mauritius, Mozambique, Namibia, Niger, Nigeria, Republic of Congo, Rwanda, São Tome and Principe, Senegal, Seychelles, Sierra Leone, Somalia, South Africa, South Sudan, Sudan, Swaziland, Tanzania, Togo, Uganda, Zambia, Zimbabwe
The Medical Education Partnership Initiative (MEPI) supports foreign institutions in sub-Saharan African countries that receive support from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) and its partners to develop or expand and enhance models of medical education. MEPI is intended to support PEPFAR's goal of increasing the number of new health care workers by 140,000, strengthen medical education systems in the countries in which they exist, and build clinical and research capacity in Africa as part of a retention strategy for faculty of medical schools and clinical professors. The program is forming a network of more than 30 regional partners, country health and education ministries, and at least 20 U.S. collaborators. MEPI is administered by Fogarty and the Health Resources and Services Administration and funded by PEPFAR and several components of NIH.
Fogarty and the National Institute of Allergy and Infectious Diseases (NIAID) have catalyzed an international effort to identify research priorities on malaria and to discuss funding mechanisms for collaborative efforts in malaria research in Africa. In 1997, following an international conference held in Dakar, Senegal, the Multilateral Initiative on Malaria (MIM) was established. MIM aims to maximize the impact of scientific research against malaria in Africa through promoting capacity building and facilitating global coordination and collaboration. MIM is an alliance of organizations and individuals concerned with malaria research and control, including donor and funder organizations (governmental, non-governmental, international agencies, and private foundations), scientists, health professionals and industry.
Stacy Wallick, M.P.H.International Program OfficerDivision of International RelationsFogarty International Center National Institutes of Health Building 31 Room B2C11 Bethesda, MD 20892-2220 Telephone: 301-496-2091 FAX: 301-480-3414Email (preferred): Stacy.Wallick@nih.gov
National Institutes of Health - NIH...Turning Discovery into Health ®